Fulcrum Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Fulcrum Therapeutics, Inc.
CIK #0001680581
EDGAR Form CIK 2011 - 2025
10-K [0001680581]
10-Q [0001680581]
3 [0001680581]
4 [0001680581]
5 [0001680581]
8-K [0001680581]
D [0001680581]
SC 13G [0001680581]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adage Capital Management LP Fulcrum Therapeutics Inc [2025-02-12]
Suvretta Capital Management LLC Fulcrum Therapeutics Inc [2025-01-06]
BlackRock Inc Fulcrum Therapeutics Inc [2024-12-06]
Nantahala Capital Management LLC Fulcrum Therapeutics Inc [2024-11-14]
BlackRock Inc Fulcrum Therapeutics Inc [2024-11-08]
BlackRock Inc Fulcrum Therapeutics Inc [2024-10-21]
TCG Crossover GP II LLC Fulcrum Therapeutics Inc [2024-09-20]
Adage Capital Partners GP LLC Fulcrum Therapeutics Inc [2023-03-06]
RA Capital Management LP Fulcrum Therapeutics Inc [2022-08-26]
Point72 Asset Management LP Fulcrum Therapeutics Inc [2022-06-22]
View All
Form 3/4/5 Subject 2011 - 2025
King Rachel K.
Fulcrum Therapeutics, Inc.
Ezekowitz Alan
Gould Robert J
Banks Sonja
Hill Colin
Haviland Kate
Dorton Katina
Geraghty James A
Tourangeau Greg
View All
Terms | Privacy | Guide
tony@aum13f.com